首页 > 最新文献

Juntendo Medical Journal最新文献

英文 中文
CSII (Continuous Subcutaneous Insulin Infusion) 療法とは CSII (Continuous Subcutaneous Insulin Infusion)疗法
Pub Date : 2012-12-31 DOI: 10.14789/PJMJ.58.485
友章 清水
{"title":"CSII (Continuous Subcutaneous Insulin Infusion) 療法とは","authors":"友章 清水","doi":"10.14789/PJMJ.58.485","DOIUrl":"https://doi.org/10.14789/PJMJ.58.485","url":null,"abstract":"","PeriodicalId":223994,"journal":{"name":"Juntendo Medical Journal","volume":"15 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2012-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115396451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Gender Differences in Secondary Prevention After Coronary Revascularization: Analysis of Diabetic Patients with Multivessel Disease 冠状动脉血运重建术后二级预防的性别差异:糖尿病合并多血管疾病患者的分析
Pub Date : 2012-10-31 DOI: 10.14789/PJMJ.58.409
Yuki Yoneda, K. Kajimoto, K. Miyauchi, Taira Yamamoto, H. Inaba, K. Tambara, S. Dohi, T. Iwamura, R. Tsuruta, Tomoaki Izawa, H. Daida, A. Amano
{"title":"Gender Differences in Secondary Prevention After Coronary Revascularization: Analysis of Diabetic Patients with Multivessel Disease","authors":"Yuki Yoneda, K. Kajimoto, K. Miyauchi, Taira Yamamoto, H. Inaba, K. Tambara, S. Dohi, T. Iwamura, R. Tsuruta, Tomoaki Izawa, H. Daida, A. Amano","doi":"10.14789/PJMJ.58.409","DOIUrl":"https://doi.org/10.14789/PJMJ.58.409","url":null,"abstract":"","PeriodicalId":223994,"journal":{"name":"Juntendo Medical Journal","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2012-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117159704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of the Effects of Alleviating Adverse Events and Improving Completion in Colorectal Cancer Patients with Postoperative Adjuvant Chemotherapy with PSK PSK对减轻结直肠癌患者术后辅助化疗不良事件及提高完成度的影响分析
Pub Date : 2012-10-31 DOI: 10.14789/PJMJ.58.422
Kiichi Sugimoto, R. Takahashi, S. Ishiyama, M. Hata, H. Kamiyama, Hiromitsu Komiyama, Makoto Takahashi, Y. Kojima, M. Goto, H. Sengoku, Y. Tomiki, K. Sakamoto
Objective :It is well known that anti-cancer drugs generate reactive oxygen species and lipoperoxides in cancer patients, and that these free radicals can give rise to adverse events. It has been reported that free radical effects might be attenuated by antioxidants. Recent reports have indicated that Protein-bound polysaccharide K(PSK) exhibits antioxidant effects in addition to its anti-tumor effects. However, there have been few reports investigating whether the antioxidant effects induced by PSK can actually alleviate the adverse events of anti-cancer drugs. In an attempt to alleviate the adverse events and improve completion of oral anti-cancer drugs, we performed a randomized, controlled trial of oral UFT / LV plus PSK as postoperative adjuvant chemotherapy for stage II and III colorectal cancer. Materials :Fifty patients who had undergone curative resection of high-risk stage II or stage III adenocarcinoma of the colon and rectum between May 2008 and May 2010 were enrolled in this study. the a 1:1 The PSK(−) and LV(75mg after and for 6 months or until the diagnosis of tumor recurrence. The PSK(+) group received PSK(3.0g / day) every day in addition to the UFT / LV treatment. Patient backgrounds, adverse events, completion of oral administration, laboratory test, stress indices, such as Reactive Oxygen Metabolites Test(d─ROMs Test) and salivary chromogranin A, and NK cell population were analyzed. Results patients(36.0%) and overall adverse events in the PSK(−) and PSK(+) groups, re-spectively. was no significant difference in the incidence of adverse events between the PSK(−) and PSK(+) groups. Twenty-two and 23 oral of anti-cancer in the PSK(−) and respectively. There was no significant difference in completion of oral administration between the two groups. In laboratory tests, no significant differences were observed between the two groups. There was no significant difference in the d─ROMs Test between the two groups. Similarly, no significant difference was observed in the salivary chromogranin A. The NK cell population in the PSK(+) group was significantly higher than that in the PSK(−) group(p=0.03).
目的:众所周知,抗癌药物在癌症患者体内产生活性氧和脂过氧化物,这些自由基可引起不良事件。据报道,抗氧化剂可以减弱自由基的作用。最近的报道表明,蛋白结合多糖K(PSK)除了具有抗肿瘤作用外,还具有抗氧化作用。然而,关于PSK诱导的抗氧化作用是否真的能减轻抗癌药物不良反应的报道很少。为了减轻口服抗癌药物的不良事件,提高口服抗癌药物的完成度,我们进行了一项随机对照试验,口服UFT / LV加PSK作为II期和III期结直肠癌术后辅助化疗。材料:本研究纳入2008年5月至2010年5月间行高危II期或III期结肠、直肠腺癌根治性切除术的患者50例。PSK(−)和LV(75mg)在肿瘤复发后和6个月或直到诊断为肿瘤复发。PSK(+)组在UFT / LV治疗的基础上,每天给予PSK(3.0g / d)。分析患者背景、不良事件、口服给药完成情况、实验室检查、应激指标(如Reactive Oxygen Metabolites test (d─ROMs test)、唾液嗜铬粒蛋白A)和NK细胞群。结果PSK组(−)和PSK组(+)患者的总不良事件发生率分别为36.0%和36.0%。不良事件发生率在PSK(−)组和PSK(+)组之间无显著差异。22和23口服抗PSK(−)和分别。两组患者口服给药的完成情况无显著差异。在实验室测试中,两组之间没有观察到显著差异。两组间的d─ROMs检验无显著差异。唾液嗜铬粒蛋白a也无明显差异,PSK(+)组NK细胞数量显著高于PSK(-)组(p=0.03)。
{"title":"Analysis of the Effects of Alleviating Adverse Events and Improving Completion in Colorectal Cancer Patients with Postoperative Adjuvant Chemotherapy with PSK","authors":"Kiichi Sugimoto, R. Takahashi, S. Ishiyama, M. Hata, H. Kamiyama, Hiromitsu Komiyama, Makoto Takahashi, Y. Kojima, M. Goto, H. Sengoku, Y. Tomiki, K. Sakamoto","doi":"10.14789/PJMJ.58.422","DOIUrl":"https://doi.org/10.14789/PJMJ.58.422","url":null,"abstract":"Objective :It is well known that anti-cancer drugs generate reactive oxygen species and lipoperoxides in cancer patients, and that these free radicals can give rise to adverse events. It has been reported that free radical effects might be attenuated by antioxidants. Recent reports have indicated that Protein-bound polysaccharide K(PSK) exhibits antioxidant effects in addition to its anti-tumor effects. However, there have been few reports investigating whether the antioxidant effects induced by PSK can actually alleviate the adverse events of anti-cancer drugs. In an attempt to alleviate the adverse events and improve completion of oral anti-cancer drugs, we performed a randomized, controlled trial of oral UFT / LV plus PSK as postoperative adjuvant chemotherapy for stage II and III colorectal cancer. Materials :Fifty patients who had undergone curative resection of high-risk stage II or stage III adenocarcinoma of the colon and rectum between May 2008 and May 2010 were enrolled in this study. the a 1:1 The PSK(−) and LV(75mg after and for 6 months or until the diagnosis of tumor recurrence. The PSK(+) group received PSK(3.0g / day) every day in addition to the UFT / LV treatment. Patient backgrounds, adverse events, completion of oral administration, laboratory test, stress indices, such as Reactive Oxygen Metabolites Test(d─ROMs Test) and salivary chromogranin A, and NK cell population were analyzed. Results patients(36.0%) and overall adverse events in the PSK(−) and PSK(+) groups, re-spectively. was no significant difference in the incidence of adverse events between the PSK(−) and PSK(+) groups. Twenty-two and 23 oral of anti-cancer in the PSK(−) and respectively. There was no significant difference in completion of oral administration between the two groups. In laboratory tests, no significant differences were observed between the two groups. There was no significant difference in the d─ROMs Test between the two groups. Similarly, no significant difference was observed in the salivary chromogranin A. The NK cell population in the PSK(+) group was significantly higher than that in the PSK(−) group(p=0.03).","PeriodicalId":223994,"journal":{"name":"Juntendo Medical Journal","volume":"7 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2012-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114874913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
A Case of Kawasaki Disease Complicated with Acute Pancreatitis After Steroid Pulse Therapy 川崎病合并急性胰腺炎经类固醇脉冲治疗1例
Pub Date : 2012-08-31 DOI: 10.14789/PJMJ.58.344
H. Suganuma, Ayako Kamata, T. Niizuma, Keiji Kinoshita, K. Obinata, Toshiaki Shimizu
{"title":"A Case of Kawasaki Disease Complicated with Acute Pancreatitis After Steroid Pulse Therapy","authors":"H. Suganuma, Ayako Kamata, T. Niizuma, Keiji Kinoshita, K. Obinata, Toshiaki Shimizu","doi":"10.14789/PJMJ.58.344","DOIUrl":"https://doi.org/10.14789/PJMJ.58.344","url":null,"abstract":"","PeriodicalId":223994,"journal":{"name":"Juntendo Medical Journal","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2012-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122798480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
乳癌の浸潤・転移・治療抵抗性のメカニズムの検討 乳腺癌的浸润、转移和治疗抵抗机制的探讨
Pub Date : 2012-08-31 DOI: 10.14789/PJMJ.58.288
史行 高橋
{"title":"乳癌の浸潤・転移・治療抵抗性のメカニズムの検討","authors":"史行 高橋","doi":"10.14789/PJMJ.58.288","DOIUrl":"https://doi.org/10.14789/PJMJ.58.288","url":null,"abstract":"","PeriodicalId":223994,"journal":{"name":"Juntendo Medical Journal","volume":"7 Suppl 1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2012-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128867021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
乳腺手術におけるazithromycin経口投与のsurgical site infection (SSI) 発生予防効果について 关于口服azithromycin乳腺手术预防surgical site infection (SSI)发生的效果
Pub Date : 2012-08-31 DOI: 10.14789/PJMJ.58.334
嘉智 伊藤, 正氣 福永, 健 須田, 憲範 平崎, 鷲尾 真理愛
{"title":"乳腺手術におけるazithromycin経口投与のsurgical site infection (SSI) 発生予防効果について","authors":"嘉智 伊藤, 正氣 福永, 健 須田, 憲範 平崎, 鷲尾 真理愛","doi":"10.14789/PJMJ.58.334","DOIUrl":"https://doi.org/10.14789/PJMJ.58.334","url":null,"abstract":"","PeriodicalId":223994,"journal":{"name":"Juntendo Medical Journal","volume":"183 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2012-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131397043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
分枝型IPMN (intraductal papillary mucinous neoplasm) の経過観察中に発生する浸潤性膵管癌に関する検討 关于在观察分枝型IPMN (intraductal papillary mucinous neoplasm)期间发生的浸润性胰管癌的讨论
Pub Date : 2012-08-31 DOI: 10.14789/PJMJ.58.330
靖 高橋, 仁煥 崔, 正文 須山, 純夫 渡辺
{"title":"分枝型IPMN (intraductal papillary mucinous neoplasm) の経過観察中に発生する浸潤性膵管癌に関する検討","authors":"靖 高橋, 仁煥 崔, 正文 須山, 純夫 渡辺","doi":"10.14789/PJMJ.58.330","DOIUrl":"https://doi.org/10.14789/PJMJ.58.330","url":null,"abstract":"","PeriodicalId":223994,"journal":{"name":"Juntendo Medical Journal","volume":"16 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2012-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114146099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serum Low-Density Lipoprotein Levels Predict Mid-Term Outcomes of Diabetic Patients After Off-Pump Coronary Artery Bypass Surgery 血清低密度脂蛋白水平预测非体外循环冠状动脉搭桥手术后糖尿病患者的中期预后
Pub Date : 2012-08-31 DOI: 10.14789/PJMJ.58.325
Tomoaki Izawa, K. Kajimoto, Taira Yamamoto, K. Miyauchi, H. Inaba, K. Tambara, S. Dohi, T. Iwamura, Yuki Yoneda, R. Tsuruta, H. Daida, A. Amano
disorders, such as higher low-density lipoprotein cholesterol(LDL─C) levels and diabetes mellitus are associated with an increased risk of adverse events in the secondary prevention of coronary artery disease. These metabolic disorders are also associated with adverse events after coronary artery bypass surgery. However, few reports describe the relationship between postoperative outcomes and preoperative serum levels of mediators including levels of fasting blood sugar (FBS), hemoglobin A1c(HbA1c) and LDL─C. This study assesses the impact of metabolic makers, including LDL─C, on mid-term outcomes of patients with diabetes after off-pump coronary artery bypass surgery. Patients :We enrolled 350 diabetic patients who underwent isolated off-pump coronary artery bypass surgery at our institu-tion between 2003 and 2007. :Predictors of all-cause death, cardiac death, and cardiac and cerebrovascular events(MACCE) the Cox proportional-hazards adjusted for LDL─C, FBS and other risk factors at
在冠状动脉疾病的二级预防中,低密度脂蛋白胆固醇(LDL─C)水平升高和糖尿病等疾病与不良事件风险增加有关。这些代谢紊乱也与冠状动脉搭桥手术后的不良事件有关。然而,很少有报道描述了术后结果与术前血清中介物水平的关系,包括空腹血糖(FBS)、血红蛋白A1c(HbA1c)和LDL─C水平。本研究评估了代谢产物(包括LDL─C)对非体外循环冠状动脉搭桥手术后糖尿病患者中期预后的影响。患者:我们招募了350名糖尿病患者,他们在2003年至2007年间在我们的机构接受了孤立的非体外循环冠状动脉搭桥手术。:全因死亡、心源性死亡和心脑血管事件(MACCE)的预测因子,经LDL─C、FBS和其他危险因素校正后的Cox比例危险度
{"title":"Serum Low-Density Lipoprotein Levels Predict Mid-Term Outcomes of Diabetic Patients After Off-Pump Coronary Artery Bypass Surgery","authors":"Tomoaki Izawa, K. Kajimoto, Taira Yamamoto, K. Miyauchi, H. Inaba, K. Tambara, S. Dohi, T. Iwamura, Yuki Yoneda, R. Tsuruta, H. Daida, A. Amano","doi":"10.14789/PJMJ.58.325","DOIUrl":"https://doi.org/10.14789/PJMJ.58.325","url":null,"abstract":"disorders, such as higher low-density lipoprotein cholesterol(LDL─C) levels and diabetes mellitus are associated with an increased risk of adverse events in the secondary prevention of coronary artery disease. These metabolic disorders are also associated with adverse events after coronary artery bypass surgery. However, few reports describe the relationship between postoperative outcomes and preoperative serum levels of mediators including levels of fasting blood sugar (FBS), hemoglobin A1c(HbA1c) and LDL─C. This study assesses the impact of metabolic makers, including LDL─C, on mid-term outcomes of patients with diabetes after off-pump coronary artery bypass surgery. Patients :We enrolled 350 diabetic patients who underwent isolated off-pump coronary artery bypass surgery at our institu-tion between 2003 and 2007. :Predictors of all-cause death, cardiac death, and cardiac and cerebrovascular events(MACCE) the Cox proportional-hazards adjusted for LDL─C, FBS and other risk factors at","PeriodicalId":223994,"journal":{"name":"Juntendo Medical Journal","volume":"156 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2012-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114646948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk Factors for Persistent Pain and Disability in Acute to Subacute Sciatica Caused by Lumbar Disk Herniation After Epidural Injections 硬膜外注射后腰椎间盘突出引起急性至亚急性坐骨神经痛持续疼痛和残疾的危险因素
Pub Date : 2012-06-30 DOI: 10.14789/PJMJ.58.231
Y. Morita, M. Iseki, I. Yonezawa, D. Nakahara, J. Sakota, T. Doi, M. Ifuku, Akira Nakao, Yoshitaka Nakamura, E. Inada
{"title":"Risk Factors for Persistent Pain and Disability in Acute to Subacute Sciatica Caused by Lumbar Disk Herniation After Epidural Injections","authors":"Y. Morita, M. Iseki, I. Yonezawa, D. Nakahara, J. Sakota, T. Doi, M. Ifuku, Akira Nakao, Yoshitaka Nakamura, E. Inada","doi":"10.14789/PJMJ.58.231","DOIUrl":"https://doi.org/10.14789/PJMJ.58.231","url":null,"abstract":"","PeriodicalId":223994,"journal":{"name":"Juntendo Medical Journal","volume":"543 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2012-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116201099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of N-acetylcysteine on Malondyaldehyde Content After Iron Treatment in Chronic Kidney Disease Stage 5D Patients 慢性肾病5D期患者铁治疗后n -乙酰半胱氨酸对丙二醛含量的影响
Pub Date : 2012-06-30 DOI: 10.14789/PJMJ.58.238
M. Thaha, M. Yusuf, Widodo, R. Anton, Putri N Wenny, Suprapti Budi, Y. Shimizu, Y. Tomino
{"title":"Effect of N-acetylcysteine on Malondyaldehyde Content After Iron Treatment in Chronic Kidney Disease Stage 5D Patients","authors":"M. Thaha, M. Yusuf, Widodo, R. Anton, Putri N Wenny, Suprapti Budi, Y. Shimizu, Y. Tomino","doi":"10.14789/PJMJ.58.238","DOIUrl":"https://doi.org/10.14789/PJMJ.58.238","url":null,"abstract":"","PeriodicalId":223994,"journal":{"name":"Juntendo Medical Journal","volume":"20 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2012-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124425034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
期刊
Juntendo Medical Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1